• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 大流行期间多发性硬化症患者的疫苗接种意愿与人格特征的关系。

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic.

机构信息

Department of Neurology, Ecumenic Hainich Hospital gGmbH, Pfafferode 102, 99974, Mühlhausen, Germany.

Department of Neurology, Neuroimmunology Section, University Medical Centre of Rostock, Gehlsheimer Str. 20, 18147, Rostock, Germany.

出版信息

Sci Rep. 2022 Sep 7;12(1):15147. doi: 10.1038/s41598-022-18912-3.

DOI:10.1038/s41598-022-18912-3
PMID:36071083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9449937/
Abstract

Vaccination is a key strategy for controlling the SARS-CoV-2 pandemic. Acceptance of SARS-CoV-2 vaccines by chronically ill patients, such as multiple sclerosis (MS) patients, plays an important role in prevention of complicated disease course. This longitudinal, prospective, multi-centre-study of German MS-patients aimed to detect socio-demographic, clinical, or psychological determinants of attitudes towards standard vaccines, SARS-CoV-2 vaccines, and governmental measures before/during the pandemic. Exactly 404 MS-patients were investigated by standardized questionnaires and structured interviews on socio-demographic, clinical-neurological, and psychological characteristics, vaccination status, and vaccination from June 2019. Data on SARS-CoV-2 vaccination willingness were collected in two follow-up assessments (1st: June to July 2020, before SARS-CoV-2 vaccine availability, N = 200; 2nd: March to May 2021, after SARS-CoV-2 vaccine availability, N = 157). Age, sex, MS course type, depression, and personality characteristics (Extraversion, Novelty seeking, Self-directedness, and Cooperativeness) were significantly associated with vaccination willingness. Although the majority of MS-patients showed SARS-CoV-2 vaccination willingness at both follow-ups (1st: 60%, 2nd: 61%), a substantial proportion had concerns and were undecided or opposed to vaccination. Socio-demographic variables like age and sex, psychopathological status, and various personality characteristics might influence vaccination willingness and should be considered when discussing with MS-patients about SARS-CoV-2 vaccination.

摘要

接种疫苗是控制 SARS-CoV-2 大流行的关键策略。慢性病患者(如多发性硬化症 [MS] 患者)对接种 SARS-CoV-2 疫苗的接受程度,对于预防疾病的复杂进程起着重要作用。本研究是一项针对德国 MS 患者的纵向、前瞻性、多中心研究,旨在发现对标准疫苗、SARS-CoV-2 疫苗和大流行期间政府措施的态度的社会人口学、临床或心理决定因素。在 2019 年 6 月,我们使用标准化问卷和关于社会人口学、临床神经学和心理特征、疫苗接种状况和疫苗接种的结构访谈,对恰好 404 名 MS 患者进行了调查。在两次随访评估中(1 次:2020 年 6 月至 7 月,在 SARS-CoV-2 疫苗可获得之前,N=200;2 次:2021 年 3 月至 5 月,在 SARS-CoV-2 疫苗可获得之后,N=157),我们收集了 SARS-CoV-2 疫苗接种意愿的数据。年龄、性别、MS 病程类型、抑郁和人格特征(外向性、寻求新奇、自我导向和合作性)与接种意愿显著相关。尽管大多数 MS 患者在两次随访中都表现出 SARS-CoV-2 疫苗接种意愿(第 1 次:60%,第 2 次:61%),但仍有相当一部分患者表示担忧,对疫苗接种犹豫不决或持反对意见。社会人口学变量,如年龄和性别、心理病理状况以及各种人格特征,可能会影响接种意愿,在与 MS 患者讨论 SARS-CoV-2 疫苗接种时应加以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8026/9452503/f265ae92e6f5/41598_2022_18912_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8026/9452503/5635327338bf/41598_2022_18912_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8026/9452503/b3e16bf1b5f3/41598_2022_18912_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8026/9452503/f265ae92e6f5/41598_2022_18912_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8026/9452503/5635327338bf/41598_2022_18912_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8026/9452503/b3e16bf1b5f3/41598_2022_18912_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8026/9452503/f265ae92e6f5/41598_2022_18912_Fig3_HTML.jpg

相似文献

1
Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic.SARS-CoV-2 大流行期间多发性硬化症患者的疫苗接种意愿与人格特征的关系。
Sci Rep. 2022 Sep 7;12(1):15147. doi: 10.1038/s41598-022-18912-3.
2
Vaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study.严重急性呼吸综合征冠状病毒 2 型大流行时期自身免疫性疾病患者的疫苗接种设定:以多发性硬化症患者为例的纵向多中心研究。
Eur Neurol. 2022;85(2):104-111. doi: 10.1159/000519582. Epub 2021 Nov 5.
3
Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis.接种 SARS-CoV-2 疫苗后的疫苗接种状况和自我报告的副作用与多发性硬化症患者的心理和临床变量有关。
Sci Rep. 2024 May 28;14(1):12248. doi: 10.1038/s41598-024-62541-x.
4
Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States.美国多发性硬化症成年人对 COVID-19 疫苗接种的意愿。
Mult Scler Relat Disord. 2021 Apr;49:102788. doi: 10.1016/j.msard.2021.102788. Epub 2021 Jan 22.
5
Change in willingness to COVID-19 vaccination in China: Two online surveys during the pandemic.中国民众对 COVID-19 疫苗接种意愿的变化:大流行期间的两项在线调查。
J Med Virol. 2022 Nov;94(11):5271-5278. doi: 10.1002/jmv.28004. Epub 2022 Jul 23.
6
Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.针对多发性硬化症患者的 SARS-CoV-2 灭活疫苗和 mRNA 疫苗的安全性和体液免疫应答率。
Mult Scler Relat Disord. 2022 Mar;59:103690. doi: 10.1016/j.msard.2022.103690. Epub 2022 Feb 13.
7
A one year follow of patients with multiple sclerosis during COVID-19 pandemic: A cross-sectional study in Qom province, Iran.伊朗库姆省 COVID-19 大流行期间多发性硬化症患者的一年随访:一项横断面研究。
Mult Scler Relat Disord. 2022 Apr;60:103712. doi: 10.1016/j.msard.2022.103712. Epub 2022 Feb 26.
8
Vaccine hesitancy among people with multiple sclerosis.多发性硬化症患者中的疫苗犹豫。
Mult Scler Relat Disord. 2021 Nov;56:103236. doi: 10.1016/j.msard.2021.103236. Epub 2021 Sep 2.
9
Antibody response to SARS-CoV-2 vaccination following typical and three-dose dosing schedules in multiple sclerosis patients treated with disease modifying therapies.多发性硬化症患者在接受疾病修正治疗后,按照典型和三剂接种方案接种 SARS-CoV-2 疫苗后的抗体反应。
Mult Scler Relat Disord. 2022 Jul;63:103856. doi: 10.1016/j.msard.2022.103856. Epub 2022 May 6.
10
Awareness of COVID-19 Symptoms, Risk Factors, and Vaccinations in Patients with Multiple Sclerosis.多发性硬化症患者对 COVID-19 症状、风险因素和疫苗接种的认知。
Int J Environ Res Public Health. 2022 Mar 12;19(6):3366. doi: 10.3390/ijerph19063366.

引用本文的文献

1
Discrepancy Between Vaccination Willingness and Actual SARS-CoV-2 Vaccination Status in People with Multiple Sclerosis: A Longitudinal Study.多发性硬化症患者接种意愿与实际新冠病毒疫苗接种状况的差异:一项纵向研究
J Clin Med. 2025 May 24;14(11):3689. doi: 10.3390/jcm14113689.
2
Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis.接种 SARS-CoV-2 疫苗后的疫苗接种状况和自我报告的副作用与多发性硬化症患者的心理和临床变量有关。
Sci Rep. 2024 May 28;14(1):12248. doi: 10.1038/s41598-024-62541-x.
3
Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study.

本文引用的文献

1
Vaccination and immunotherapies in neuroimmunological diseases.神经免疫性疾病的疫苗接种和免疫疗法。
Nat Rev Neurol. 2022 May;18(5):289-306. doi: 10.1038/s41582-022-00646-5. Epub 2022 Apr 6.
2
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.英国未接种和接种疫苗人群中 SARS-CoV-2 德尔塔(B.1.617.2)变异株的社区传播和病毒载量动力学:一项前瞻性、纵向、队列研究。
Lancet Infect Dis. 2022 Feb;22(2):183-195. doi: 10.1016/S1473-3099(21)00648-4. Epub 2021 Oct 29.
3
Vaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study.
接种疫苗后多发性硬化症的副作用:一项前瞻性、多中心队列研究。
Sci Rep. 2023 Sep 2;13(1):14480. doi: 10.1038/s41598-023-41271-6.
4
Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study.多发性硬化症患者接种新型冠状病毒疫苗后复发的频率及预测因素:一项纵向观察性研究的中期结果
J Clin Med. 2023 May 24;12(11):3640. doi: 10.3390/jcm12113640.
5
Neuroticism predicts national vaccination rates across 56 countries.神经质人格特质可预测56个国家的全国疫苗接种率。
Curr Psychol. 2023 Jan 21:1-6. doi: 10.1007/s12144-023-04234-8.
严重急性呼吸综合征冠状病毒 2 型大流行时期自身免疫性疾病患者的疫苗接种设定:以多发性硬化症患者为例的纵向多中心研究。
Eur Neurol. 2022;85(2):104-111. doi: 10.1159/000519582. Epub 2021 Nov 5.
4
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial.新冠疫情:研究人员揭露辉瑞疫苗试验中的数据完整性问题。
BMJ. 2021 Nov 2;375:n2635. doi: 10.1136/bmj.n2635.
5
Menstrual changes after covid-19 vaccination.新冠疫苗接种后的月经变化。
BMJ. 2021 Sep 15;374:n2211. doi: 10.1136/bmj.n2211.
6
Factors That Shape People's Attitudes towards the COVID-19 Pandemic in Germany-The Influence of MEDIA, Politics and Personal Characteristics.影响德国人对新冠大流行态度的因素——媒体、政治和个人特征的影响。
Int J Environ Res Public Health. 2021 Jul 22;18(15):7772. doi: 10.3390/ijerph18157772.
7
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic.新冠疫情时代的疫苗接种与多发性硬化症
J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1033-1043. doi: 10.1136/jnnp-2021-326839. Epub 2021 Aug 5.
8
The overlooked superpower of mRNA vaccines.mRNA疫苗被忽视的强大力量。
Science. 2021 Jul 30;373(6554):479. doi: 10.1126/science.373.6554.479.
9
Journal retracts paper claiming COVID-19 vaccines kill.期刊撤回声称新冠疫苗会致死的论文。
Science. 2021 Jul 9;373(6551):147. doi: 10.1126/science.373.6551.147.
10
COVID-19 vaccination willingness among people with multiple sclerosis.多发性硬化症患者的新冠病毒疫苗接种意愿
Mult Scler J Exp Transl Clin. 2021 May 31;7(2):20552173211017159. doi: 10.1177/20552173211017159. eCollection 2021 Apr-Jun.